Methylation signatures of pathogen and chemical exposures in human cells
AssigneeThe Salk Institute for Biological Studies
InventorsWenliang Wang, Manoj Hariharan, Joseph R. Ecker
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Salk Institute for Biological Studies
InventorsWenliang Wang, Manoj Hariharan, Joseph R. Ecker
Estimating the term…
Methods are provided for determining whether a subject has been exposed to or infected with Bacillus anthracis, SARS-CoV-2, influenza A, human immunodeficiency virus type 1 (HIV-1), methicillin-susceptible Staphylococcus aureus (MSSA), or methicillin-resistant Staphylococcus aureus (MRSA), or has been exposed to an organophosphate (OP). Such methods include determining the measuring methylation status of numerous differentially methylated regions (DMRs) in the genomic DNA of particular PBMCs, such as those provided in Table 1, and in some examples also determining an amount of accessible chromatin in the isolated immune cells. Also provided are nucleic acid probes, arrays, solid supports (such a chip or nanosphere) and kits that can be used with such methods.
A method of determining whether a subject has been exposed to or infected with Bacillus anthracis, SARS-CoV-2, human immunodeficiency virus type 1 (HIV-1), influenza A, methicillin-resistant Staphylococcus aureus (MSSA), or methicillin-resistant Staphylococcus aureus (MRSA), or has been exposed to an organophosphate (OP), comprising:
A kit, comprising:
Dependencies are inferred from the claim text.